Update on ELOQUENT-2: Phase 3 trial of elotuzumab in relapsed/refractory multiple myeloma

Sagar Lonial, MD from Emory University Winship Cancer Institute, Atlanta, GA gives an overview of the ELOQUENT-2 clinical trial of lenalidomide/dexamethasone with/without elotuzumab in patients with r... Author: VJHemOnc Added: 02/09/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts